title: Optimizing hepatitis B vaccination in prison.
abstract: OBJECTIVE
  We aimed to establish the current status of hepatitis B virus (HBV) vaccination in prison.
  
  
  METHODS
  We carried out two evaluations within a 1-year interval with inmates incarcerated for 6 to 12 months. A monitoring process was introduced in-between the two evaluations.
  
  
  RESULTS
  We included 231 inmates. Overall, 42.9% were immunized because of a previous vaccination and 14.3% because of a previous exposure. Inmates born in an area of medium or high endemicity for HBV were significantly more exposed to HBV. The proportion of non-immunized inmates was 42.8% at the time of incarceration and 27.5% after 6 to 12 months. Vaccination coverage with two doses, after 6 to 12 months, was 63% among patients who were initially non-immunized.
  
  
  CONCLUSIONS
  The recently developed accelerated vaccination schedule should help improve HBV vaccination coverage.
authors.affiliation: UCSA de la Maison d'arrêt Bordeaux-Gradignan, BP 109, 33173 Gradignan cedex, France. Electronic address: florenceperrodeau@gmail.com.
authors.forename: F
authors.initials: F
authors.lastname: Perrodeau
authors.affiliation: UCSA de la Maison d'arrêt Bordeaux-Gradignan, BP 109, 33173 Gradignan cedex, France. Electronic address: marie.pillot@chu-bordeaux.fr.
authors.forename: M
authors.initials: M
authors.lastname: Pillot-Debelleix
authors.affiliation: Service d'hépato-gastro-entérologie et d'oncologie, groupe hospitalier Sud, groupe hospitalier Haut-Lévêque, 1, avenue Magellan, 33600 Pessac, France. Electronic address: julien.vergniol@chu-bordeaux.fr.
authors.forename: J
authors.initials: J
authors.lastname: Vergniol
authors.affiliation: UCSA de la Maison d'arrêt Bordeaux-Gradignan, BP 109, 33173 Gradignan cedex, France. Electronic address: fabienne.lemonnier@chu-bordeaux.fr.
authors.forename: F
authors.initials: F
authors.lastname: Lemonnier
authors.affiliation: Unité des maladies tropicales et du voyageur, service des maladies infectieuses et tropicales, groupe hospitalier Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. Electronic address: marie-catherine.receveur@chu-bordeaux.fr.
authors.forename: M-C
authors.initials: MC
authors.lastname: Receveur
authors.affiliation: Laboratoire de microbiologie fondamentale et pathogénicité, UMR-CNRS 5234, bâtiment 2A, 3(e) étage, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France. Electronic address: pascale.trimoulet@chu-bordeaux.fr.
authors.forename: P
authors.initials: P
authors.lastname: Trimoulet
authors.affiliation: Service de médecine interne et des maladies infectieuses (Sud), groupe hospitalier Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. Electronic address: isabelle.raymond@chu-bordeaux.fr.
authors.forename: I
authors.initials: I
authors.lastname: Raymond
authors.affiliation: UCSA de la Maison d'arrêt Bordeaux-Gradignan, BP 109, 33173 Gradignan cedex, France. Electronic address: gildas.le-port@chu-bordeaux.fr.
authors.forename: G
authors.initials: G
authors.lastname: Le Port
authors.affiliation: Unité de médecine légale, institut médico-judiciaire, groupe hospitalier Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. Electronic address: sophie.gromb@chu-bordeaux.fr.
authors.forename: S
authors.initials: S
authors.lastname: Gromb-Monnoyeur
mesh_terms: D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines; D006801:Humans; D008297:Male; D011330:Prisons; D012189:Retrospective Studies; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D017325:Hepatitis B Vaccines
keywords: HBV; Prison; VHB; Vaccination